Cassava Sciences (SAVA) Hits Low, Down 24%
- Global stocks eye new high on growth hopes, oil ebbs on COVID-19 fears
- Oil extends losses on U.S. stock build, pandemic concerns
- Cathie Wood's ARK Buys Over 5M Shares of Skillz (SKLZ), Nearly 3M Shares of IPO UiPath (PATH)
- Chipotle Mexican Grill (CMG) Tops Q1 Profit Views, Analysts Maintain Bullishness For 2021
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
Cassava Sciences (NASDAQ: SAVA) Hits Low, Down 24%
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cassava Sciences Reports First Quarter 2021 Financial Results and Announces Guidance on Clinical Data Release
- Harley-Davidson (HOG) Soars 10% on Beat-and-Raise, Plans to Appeal European Union 56% Tariff
- Manchester United (MANU) Up 9% on Plans to Join a New European Super League, a New Competition Format Funded by JP Morgan